On Friday, the competition regulator of Britain approved Amazon.com Inc’s acquisition of iRobot for $1.7 billion, which is the manufacturer of the Roomba vacuum cleaner.
Reuters reported that the CMA found no competition issues in the UK related to the deal.
“We’re pleased with the UK Competition and Markets Authority’s decision and are committed to supporting regulatory bodies in their work,” a spokesperson for Amazon said. “We look forward to similar decisions from other regulators soon.”
Related: UK Watchdog Probes Amazon’s $1.7B iRobot Acquisition
The CMA initiated a “Phase 1” investigation into Amazon’s acquisition of smart-home devices in August 2020, which includes the Alexa voice assistant, smart thermostats, security devices, wall-mounted smart displays, and a canine-like robot named Astro. The probe was launched in April.
Regulators on both sides of the Atlantic are cautious about Big Tech acquiring smaller competitors, particularly those with access to significant amounts of user data, and typically require concessions before approving such transactions.
“It marks a significant milestone, and both companies are continuing to work cooperatively with other relevant regulators in their review of the merger,” iRobot Chief Executive Colin Angle said in a statement.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI